Carbonic anhydrase IX is expressed in mesothelioma and metastatic clear cell renal cell carcinoma of the lung

Virchows Archiv

Volumn 460, Issue 1, 2012, Pages 89-93

  Ramsey, Mitchell L ^a   Yuh, Benjamin J ^a   Johnson, Matthew T ^a   Yeldandi, Anjana V ^b   Zynger, Debra L ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

CAIX; Carbonic anhydrase IX; Clear cell renal cell carcinoma; Lung; Mesothelioma; Metastatic

Indexed keywords

CARBONATE DEHYDRATASE IX;

ADENOCARCINOMA; ADENOMATOID TUMOR; ANTIGEN EXPRESSION; ARTICLE; CLEAR CELL CARCINOMA; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; KIDNEY CARCINOMA; LUNG METASTASIS; MESOTHELIOMA; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ANTIGENS, NEOPLASM; BIOPSY; CARBONIC ANHYDRASES; CARCINOMA, RENAL CELL; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MESOTHELIOMA; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84857043054     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-011-1178-7     Document Type: Article

References (27)

1. Stillebroer AB, Mulders PFA, Boerman OC et al (2010) Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy. Eur Urol 58:75-83
2. Kon-no H, Ishii G, Nagai K et al (2006) Carbonic anhydrase IX expression is associated with tumor progression and a poor prognosis of lung adenocarcinoma. Lung Cancer 54(3):409-418 (Pubitemid 44634145)
3. Leibovich BC, SheininY, LohseCMet al (2007) Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma. J Clin Oncol 25:4757-4764 (Pubitemid 350086478)
4. Malentacchi F, Simi L, Nannelli C et al (2009) Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer. Lung Cancer 64:271-276
5. Patard J, Fergelot P, Karakiewicz PI et al (2009) Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma. Int J Cancer 123(2):395-400 (Pubitemid 351842025)
6. Ivanov S, Liao SY, Ivanova A et al (2001) Expression of hypoxiainducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol 158(3):905-919 (Pubitemid 32221783)
7. Tostain J, Li G, Gentil-Perret A et al (2010) Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment. Eur J Cancer 46:3141-3148
8. Liao SY, Aurelio ON, Jan Ket al (1997) Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res 57:2827-2831 (Pubitemid 27315020)
9. Genega EM, Ghebremichael M, Najarian R et al (2010) Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade. Am J Clin Pathol 134:873-879
10. Leppert JT, Lam JS, Pantuck AJ et al (2005) Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma. BJU Int 96:281-285 (Pubitemid 41097666)
11. Al-Hamadie HA, Alden D, Qin LX et al (2008) Carbonic anhydrase IX expression in clear cell renal cell carcinoma: an immunohistochemical study comparing 2 antibodies. Am J Surg Pathol 32 (3):377-382 (Pubitemid 351398928)
12. McNicholsDW, Segura JW, DeWeerd JH (1981) Renal cell carcinoma: long-term survival and late recurrence. J Urol 126:17-23 (Pubitemid 11033860)
13. Janzen NK, Kim HL, Figlin RA et al (2003) Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am 30:843-852 (Pubitemid 37485197)
14. Bukowski RM (1997) Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2. Cancer 80:1198-1220 (Pubitemid 27407220)
15. Motzer RJ, Bacik J, Mariani T et al (2002) Treatment outcome and survival associated with metastatic renal cell carcinoma of nonclear- cell histology. J Clin Oncol 20:2376-2381 (Pubitemid 34441667)
16. Winum JY, Scozzafava A, Montera JL et al (2009) Inhibition of carbonic anhydrase IX: a new strategy against cancer. Anticancer Agents Med Chem 9:693-702
17. Li G, Passebosc-Faure K, Feng G et al (2007) MN/CA9: a potential gene marker for detection of malignant cells in effusions. Biomarkers 12(2):214-220 (Pubitemid 47161401)
18. Ilie M, Mazure NM, Hofman Vet al (2010) High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer. Br J Cancer 102:1627-1635
19. Travis WD, Brambilla E, Muller-Hermelink HK et al (2004) World Health Organization classification of tumors: pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC, Lyon
20. Choueiri TK, Regan MM, Rosenberg JE et al (2010) Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy. BJU Int 106:772-778
21. Bui MH, Seligson D, Han K et al (2003) Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res 9:802-811 (Pubitemid 36182618)
22. Tickoo SK, Alden D, Olgac S (2007) Immunohistochemical expression of hypoxia inducible factor-1α and its downstream molecules in sarcomatoid renal cell carcinoma. J Urol 177:1258-1263 (Pubitemid 46436019)
23. Kim SJ, Rabbani ZN, Vollmer RT (2004) Carbonic anhydrase IX in early-stage non-small cell lung cancer. Clin Cancer Res 10:7925-7933 (Pubitemid 39587532)
24. Kim SJ, Rabbani ZN, Dewhirst MW (2005) Expression of HIF- 1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer. Lung Cancer 49:325-335 (Pubitemid 41139145)
25. Vermylen P, Roufosse C, Burny A (1999) Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma. Eur Respir J 14:806-811 (Pubitemid 29519341)
26. Atkins M, Regan M, McDermott D (2005) Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer. Clin Cancer Res 11(10):3714-3721 (Pubitemid 40685588)
27. Atkins MB, Choueiri TK, Cho D (2009) Treatment selection for patients with metastatic renal cell carcinoma. Cancer 115(10):2327-2333